Safety of bronchial artery infusion immunotherapy: from comparative analysis in beagle canines to clinical validation
Our study suggest the preliminary safety and feasibility of delivering aPD-1 mAb via BAI in both canine models and NSCLC patients.
Authors
- Jia Zhou (ORCID: https://orcid.org/0000-0002-2811-1090)
- Xiaocheng Cheng
- Bo Xie
- Bin Liu (ORCID: https://orcid.org/0000-0001-7890-7612)
- Yueming Zhang (ORCID: https://orcid.org/0000-0003-1109-8253)
- Rui Zhang (ORCID: https://orcid.org/0000-0003-3740-8352)
- Xu Li (ORCID: https://orcid.org/0000-0002-0929-1428)
- Shuliang Guo
- Wei He (ORCID: https://orcid.org/0000-0002-3100-9724)
Institutions
- Central South University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Zhuzhou Central Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1007/s12672-025-02398-2
- Citations
- 1
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80